Whether all obese subjects both in metabolic groups and non-metabolic groups should be treated or not

Journal of Diabetes and Metabolic Disorders

Volumn 13, Issue 1, 2014, Pages

  Payab, Moloud ^a   Hasani Ranjbar, Shirin ^a,b   Larijani, Bagher ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Metabolic disorder; Obesity; Osteoarthritis; Sleep disorders

Indexed keywords

ABDOMINAL OBESITY; BODY MASS; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; EDITORIAL; HIP OSTEOARTHRITIS; HUMAN; KIDNEY DISEASE; KNEE OSTEOARTHRITIS; METABOLIC SYNDROME X; MORTALITY; OBESITY; PHENOTYPE; RISK ASSESSMENT; SLEEP DEPRIVATION; SLEEP DISORDER;

EID: 84908213247     PISSN: None     EISSN: 22516581     Source Type: Journal    
DOI: 10.1186/2251-6581-13-21     Document Type: Editorial

References (13)

1. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization technical report series 2000, 894:i-xii. 1-253.
2. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know?. J Clin Endocrinol Metab 2004, 89(6):2569-2575. 10.1210/jc.2004-0165, 15181025.
3. Koonce RC, Bravman JT. Obesity and osteoarthritis: more than just wear and tear. J Am Acad Orthop Surg 2013, 21(3):161-169. 10.5435/JAAOS-21-03-161, 23457066.
4. Rtveladze K, Marsh T, Webber L, Kilpi F, Levy D, Conde W, et al. Health and economic burden of obesity in Brazil. PLoS One 2013, 8(7):e68785. 10.1371/journal.pone.0068785, 3708916, 23874763.
5. Hargens TA, Kaleth AS, Edwards ES, Butner KL. Association between sleep disorders, obesity, and exercise: a review. Nat Sci Sleep 2013, 5:27-35. 3630986, 23620691.
6. Soriguer F, Gutierrez-Repiso C, Rubio-Martin E, Garcia-Fuentes E, Almaraz MC, Colomo N, et al. Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J Clin Endocrinol Metab 2013, 98(6):2318-2325. 10.1210/jc.2012-4253, 23559087.
7. Sims EA. Are there persons who are obese, but metabolically healthy?. Metab Clin Exp 2001, 50(12):1499-1504. 10.1053/meta.2001.27213, 11735101.
8. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008, 168(15):1609-1616. 10.1001/archinte.168.15.1609, 18695074.
9. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008, 168(15):1617-1624. 10.1001/archinte.168.15.1617, 18695075.
10. Karelis AD, Rabasa-Lhoret R. Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals. Diabetes Metab 2008, 34(2):183-184. 10.1016/j.diabet.2007.11.004, 18329310.
11. Appleton SL, Seaborn CJ, Visvanathan R, Hill CL, Gill TK, Taylor AW, et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care 2013, 36(8):2388-2394. 10.2337/dc12-1971, 23491523.
12. National Institutes of Health Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults--the evidence report. Obes Res 1998, 6(2):51S-209S. National Institutes of Health.
13. Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 2012, 97(7):2482-2488. 10.1210/jc.2011-3475, 3387408, 22508708.